3623 results for «87»
3623 results
TAVI: haemodynamic considerations
19 Nov 2023 – From PCR London Valves 2023
Consult this session to gain a comprehensive understanding of the hemodynamic considerations in TAVI: delve into the comparative analysis of invasive and echocardiographic assessments to discern transvalvular pressure gradients post-TAVI, witness the validation of non-invasive volume-pressure loop analysis as an effective tool for patients with aortic...
Mitral Late-Breaking Trials: CLASP IID, AltaValve transseptal programme, MitraSwiss in men and women, MiCLASP...
19 Nov 2023 – From PCR London Valves 2023
Discover the mitral late-breaking trials which were presented during PCR London Valves 2023:
- One-year outcomes of transcatheter mitral repair from the CLASP IID Registry
- AltaValve transseptal programme update
- Mitral TEER in men and women from MitraSwiss registry: is equality achieved?
- Combined impact of mitral valve gradients and mitral regurgitation reduction...
TAVI in bicuspid anatomy - Part 1
19 Nov 2023 – From PCR London Valves 2023
Delve into the complexities of TAVI within bicuspid anatomy through this selection of cases: encounter a challenging scenario with a bicuspid aortic valve, where the ejection fraction is -14%, coupled with left ventricle thrombus and an aortic valve calcium score reaching 11,000, learn more about the...
TAVI outcomes - Part 1
19 Nov 2023 – From PCR London Valves 2023
Learn more about TAVI outcomes with this session: examine the impact of high-gradient and discordant low-gradient aortic stenosis, discover the potential of patient-specific computer simulation, explore the critical factor of time to TAVI and its implications in decompensated aortic stenosis cases, dive into the POPular TAVI...
Challenging situations and complications in patients with ACS and acute heart failure undergoing PCI
14 May 2024 – From EuroPCR 2024
This session, with the collaboration of various national societies, focuses on understanding different approaches and techniques for managing challenging situations and complications in patients with ACS and acute heart failure undergoing PCI. It covers the prompt recognition of potential periprocedural complications, various management strategies for PCI...
Mechanical circulatory support in cardiogenic shock and high-risk PCI
14 May 2024 – From EuroPCR 2024
This session, comprising selected EuroPCR 2024 Abstract submissions, focuses on the use of mechanical circulatory support in cardiogenic shock and high-risk PCI. It includes presentations and discussions on lowering cardiogenic shock mortality through a comprehensive mechanical circulatory support approach, the use of lactate and lactate clearance...
Align for the future with next-generation balloon expandable transcatheter heart valve technology
14 May 2024 – From EuroPCR 2024
Tune in to this EuroPCR 2024 session to explore the Myval Octacor THV, a cutting-edge balloon-expandable transcatheter heart valve. Discover its advanced features, potential clinical benefits, and procedural impact. Learn about the latest updates on the Myval THV series and the LANDMARK RCT. Explore the OctaAlign technique for...
CTO PCI: what a surprise!
14 May 2024 – From EuroPCR 2024
This session, comprising selected EuroPCR 2024 Clinical Case submissions, explores various challenging and unexpected scenarios encountered during CTO PCI procedures. It includes case presentations and discussions on guide wire entrapment and removal, subintimal wiring, revitalizing hope in a low ejection fraction patient, physiologic and hemodynamic considerations...
Clinical adoption of renal denervation: no more excuses
15 May 2024 – From EuroPCR 2024
Sirolimus-coated balloon: exploring the case- and clinical-based evidences
16 May 2024 – From EuroPCR 2024
Browse this EuroPCR 2024 session to explore the safety and efficacy of sirolimus-coated balloons from pre-clinical data, review MagicTouch data from real-world populations with case-based examples, and learn about the MagicTouch sirolimus-coated balloon clinical programs. Discover insights and takeaways from the significance of the EASTBOURNE subgroups,...
Go beyond metal: exploring drug-eluting balloon technology in de-novo coronary lesions
15 May 2024 – From EuroPCR 2024
Through the study of two cases, this session examines the need for stenting bifurcation lesions and the role of DEB technology in avoiding stent-related complications in long diffuse disease. It emphasizes the benefits of SELUTION SLR balloons for de novo lesions, discussing how sustained limus release...
Identification and treatment of (sub)clinical transcatheter valve thrombosis
16 May 2024 – From EuroPCR 2024
This session offers a practical guide to CT diagnosis of HALT/RLM, highlighting the importance of taking HALT/RLM seriously and providing insights into approaching HALT/HAM and the potential impact of pharmacotherapy. Gain knowledge on determining leaflet thickening and mobility through MSCT, receive updates on antithrombotic treatment strategies...
Challenging scenarios in NSTEMI
16 May 2024 – From EuroPCR 2024
This session features selected clinical case submissions that explore complex and challenging scenarios encountered in the management of NSTEMI patients. Participants will delve into discussions on topics such as coronary artery aneurysm, restenosis of coronary ostial stents, right-sided chest pain, subsequent occlusions of the left anterior...
PCI of calcified lesions
16 May 2024 – From EuroPCR 2024
This session delves into the treatment of calcified lesions, providing a comprehensive overview of contemporary tools and techniques for optimal plaque modification. Attendees will learn through a series of case presentations, where experts dissect challenging cases involving severe coronary calcification, including in the left main trunk....
The value of IVUS during CTO PCI
16 May 2024 – From EuroPCR 2024
This session explores the role of IVUS imaging in the management of chronic total occlusions (CTOs) during PCI procedures. Participants will learn how IVUS can help in navigating the true lumen, utilizing retrograde plaque/flap lift-and-shift techniques, managing false lumen entry, and addressing other challenging scenarios in...
State-of-the-art on left main interventions in Latin America
16 May 2024 – From EuroPCR 2024
This session, in collaboration with the Sociedad Latino Americana de Cardiologia Intervencionista (SOLACI), provides insights into the management of left main coronary artery disease in Latin America. Attendees will learn about the revascularization guidelines for left main in the region, the approaches to left main bifurcations...
Challenging LAA occlusion cases
16 May 2024 – From EuroPCR 2024
This session features selected clinical case submissions that explore complex and challenging scenarios in left atrial appendage (LAA) occlusion procedures. Participants will learn about techniques for rescuing a migrating LAA occluder, managing incomplete surgical LAA ligation, and utilizing specialized techniques like the "kissing" approach for LAA...
Trial updates and featured clinical research
16 May 2024 – From EuroPCR 2024
This session showcases a selection of the latest clinical research and trial updates presented at EuroPCR 2024. Attendees will have the opportunity to learn about the findings from studies evaluating the use of OCT-guided PCI for chronic total occlusions, the safety and efficacy of short dual...
Multivessel disease PCI guided by physiology and IVUS - LIVE case
16 May 2024 – From EuroPCR 2024
A 78-year-old woman with hypertension, dyslipidemia, and obesity, presented with angina CCS2 and preserved LV function. The coronary angiogram showed stenosis in the RCA (proximal and mid), CX, and calcified proximal and mid LAD involving D1 and D2.
The operators performed PCI on the RCA (1 stent)...
Comparative insights into QFR, FFR, and angiography
16 May 2024 – From EuroPCR 2024
This session, comprising selected EuroPCR 2024 Abstract submissions, focuses on various aspects of assessing and managing multivessel coronary artery disease. It includes presentations and discussions on the use of quantitative flow ratio (QFR) for assessing non-culprit lesions in acute myocardial infarction, functional assessment of surgical revascularization,...
